Cargando…
Autophagy: a new target for nonalcoholic fatty liver disease therapy
Nonalcoholic fatty liver disease (NAFLD) has gained importance in recent decades due to drastic changes in diet, especially in Western countries. NAFLD occurs as a spectrum from simple hepatic steatosis, steatohepatitis to cirrhosis, and even hepatocellular carcinoma. Although the molecular mechanis...
Autores principales: | Mao, Yuqing, Yu, Fujun, Wang, Jianbo, Guo, Chuanyong, Fan, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822806/ https://www.ncbi.nlm.nih.gov/pubmed/27099536 http://dx.doi.org/10.2147/HMER.S98120 |
Ejemplares similares
-
Ghrelin Attenuates Liver Fibrosis through Regulation of TGF-β1 Expression and Autophagy
por: Mao, Yuqing, et al.
Publicado: (2015) -
Ghrelin reduces liver impairment in a model of concanavalin A-induced acute hepatitis in mice
por: Mao, Yuqing, et al.
Publicado: (2015) -
Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
por: Lu, Wenxia, et al.
Publicado: (2016) -
Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease
por: Huang, Yuanshe, et al.
Publicado: (2022) -
Metabolic Targets in Nonalcoholic Fatty Liver Disease
por: Esler, William P., et al.
Publicado: (2019)